The Effect of Dydrogesterone on Sexual Function in Women With Endometriosis

Kanuni Sultan Suleyman Training and Research Hospital79 enrolled

Overview

This study aimed to assess the effects of dydrogesterone on sexual function in women with endometriosis using Female Function Sexual Index (FSFI).

Sexual dysfunction is an important outcome for patients with endometriosis. In this study, we compare the fsfi (female sexual function index) questions and the scores before and after dydrogesterone treatment in patients with endometriosis. We aim to measure the effect of dydrogesterone in patients with endometriosis.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Endometriosis Sexual Dysfunction

Interventions

DydrogesteroneDRUG

79 women, aged between 18 and 45 years, who were examined at our tertiary gynecology outpatient clinic between April 2019 and March 2020, with surgically diagnosed endometriosis, were included in this study. They received a treatment with 5 mg dydrogesterone administered orally twice daily for 21 days; from the 5th to 25th day of each menstrual cycle, for a total of 6 months. They were evaluated pre- and posttreatment in terms of their age, parity, and body mass index (BMI). Female Function Sexual Index (FSFI) and visual analogue scale (VAS) scores were recorded pre- and posttreatment

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * no history of malignancies, * normal findings at gynecological examinations and transvaginal ultrasonography * normal uterine size, normal cervical smear results, * patients not use any contraception methods in the last 6 months Exclusion Criteria: * with a history of systemic and/or psychiatric diseases, * gynecological pathologies (myoma uteri, endometriosis, uterine anomalies, existing genital infections) * pelvic organ prolapse * pelvic surgeries

Locations (1)

Pinar Yalcin Bahat

Istanbul, İ̇stanbul, Turkey (Türkiye)

Outcomes

Primary Outcomes

The Effect of Dydrogesterone on Sexual Function

In this study, we compare the fsfi(female sexual function index) questions and the scores before and after dihydrogestreone treatment in patients with endometriosis. We aim to measure the effect of dihydrogesterone in patients with endometriosis.

Time frame: 6 months

Secondary Outcomes

The Effect of Dydrogesterone on Sexual Function in women with endometrioma

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.